i

Remote electronic fetal heart and vital signs monitoring in a COVID-19 referral hospital in the Philippines using a locally made monitoring device: RxBox Version 2

PHRR210930-003971

Remote electronic fetal heart and vital signs monitoring in a COVID-19 referral hospital in the Philippines using a locally made monitoring device: RxBox Version 2

The use of a locally made telemedicine device, RxBox version 2, among pregnant patients infected with COVID-19, is described. A retrospective descriptive study of the use of RxBox version 2 was conducted in a tertiary hospital in the Philippines, which was designated as a COVID-19 referral hospital in March 2020.

Regime Classification Priority
2017 - 2022 Global competitiveness and innovation in health Access to essential medical products, vaccines and technologies
Start Date Duration in Months Target Completion Date Actual Completion Date
2020-10-01 6 2021-04-01 2021-06-01

Completed

Institution Classification Region LTO #
University of the Philippines - Philippine General Hospital Government NCR
Institution Classification Region LTO #
None None None
Institution Region
University of the Philippines NCR
Name E-Mail Institution and Institution Address
Koleen C. Pasamba koko.c.pasamba@gmail.com Philippine General Hospital
Name E-Mail Institution and Institution Address
Koleen C. Pasamba koko.c.pasamba@gmail.com Philippine General Hospital
Name Expertise Affiliation
Angela S. Aguilar REI University of the Philippines
Koleen Pasamba, MD MD University of the Philippines

Telemedicine provides an opportunity to deliver safe and effective care for women with COVID-19 during this pandemic. It overcomes the limitations of monitoring of these patients by providing real time data to health personnel remotely. The use of a locally made telemedicine device, RxBox version 2, among pregnant patients infected with COVID-19, is described.

A total of 28 patients were included in the study whom maternal characteristics, vital signs, fetal heart monitoring and neonatal outcomes were collected. The mean, standard deviation, frequency and percentage were determined. Majority of the cases monitored had mild COVID-19 (75 %) while the rest were moderate to critical.  The device was used for patients with complications such as hypertension (17.9%) and diabetes (10.7%). About 21.3 % of all traces were categorized as non-reassuring.

During the COVID-19 pandemic, the locally-made monitoring device, RxBox version 2, enabled continuous and remote monitoring of patients infected with COVID-19 providing information that influenced clinical management. 

Completed

Non-clinical Studies

©2022 HERDIN PLUS. All rights reserved. | Contact Us | Keep up to date